Verastem (VSTM) Share-based Compensation (2011 - 2026)
Verastem's quarterly Share-based Compensation came in at $2.0 million in Q1 2026, up 14.43% year-on-year from $1.8 million in Q1 2025, and up 1.04% quarter-over-quarter from $2.0 million in Q4 2025.
Verastem has reported Share-based Compensation for 16 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 14.43% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (up 26.35% YoY), and the FY2025 full-year result was $9.4 million, up 28.08% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.0 million, up from $2.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $3.4 million in Q2 2025, with the low at $1.3 million in Q4 2022.
- Average Share-based Compensation over 5 years is $1.8 million, with a median of $1.8 million recorded in 2022.
- Year-over-year, Share-based Compensation sank 31.76% in 2022 and surged 79.16% in 2025.
- Tracing VSTM's Share-based Compensation over 5 years: stood at $1.3 million in 2022, then climbed by 24.16% to $1.6 million in 2023, then increased by 26.35% to $2.0 million in 2024, then grew by 0.3% to $2.0 million in 2025, then gained by 1.04% to $2.0 million in 2026.
- The last three Share-based Compensation figures came in at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.31 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.36 Mn |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 2.93 Mn |
| Dec 31, 2020 | 2.93 Mn |
| Sep 30, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 1.66 Mn |
| Jun 30, 2020 | 1.66 Mn |
| Mar 31, 2020 | 1.37 Mn |
| Mar 31, 2020 | 1.37 Mn |
| Dec 31, 2019 | 1.31 Mn |
| Dec 31, 2019 | 1.31 Mn |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 2.25 Mn |
| Mar 31, 2019 | 2.25 Mn |
| Dec 31, 2018 | 1.76 Mn |
| Dec 31, 2018 | 1.76 Mn |
| Sep 30, 2018 | 200,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Mar 31, 2018 | 1.33 Mn |
| Mar 31, 2018 | 1.33 Mn |
| Dec 31, 2017 | 963,000.00 |
| Dec 31, 2017 | 963,000.00 |
| Sep 30, 2017 | 379,000.00 |
| Sep 30, 2017 | 379,000.00 |
| Jun 30, 2017 | 1.21 Mn |
| Jun 30, 2017 | 1.21 Mn |
| Mar 31, 2017 | 1.20 Mn |
| Mar 31, 2017 | 1.20 Mn |
| Dec 31, 2016 | -4.54 Mn |
| Dec 31, 2016 | -4.54 Mn |
| Sep 30, 2016 | 1.31 Mn |
| Sep 30, 2016 | 1.31 Mn |
| Jun 30, 2016 | 1.73 Mn |
| Jun 30, 2016 | 1.73 Mn |
| Mar 31, 2016 | 1.71 Mn |
| Mar 31, 2016 | 1.71 Mn |
| Dec 31, 2015 | 2.04 Mn |
| Dec 31, 2015 | 2.04 Mn |
| Sep 30, 2015 | 2.38 Mn |
| Sep 30, 2015 | 2.38 Mn |
| Jun 30, 2015 | 2.54 Mn |
| Jun 30, 2015 | 2.54 Mn |
| Mar 31, 2015 | 3.13 Mn |
| Mar 31, 2015 | 3.13 Mn |
| Dec 31, 2014 | 2.04 Mn |
| Dec 31, 2014 | 2.04 Mn |
| Sep 30, 2014 | 3.16 Mn |
| Sep 30, 2014 | 3.16 Mn |
| Jun 30, 2014 | 2.93 Mn |
| Jun 30, 2014 | 2.93 Mn |
| Mar 31, 2014 | 3.99 Mn |
| Mar 31, 2014 | 3.99 Mn |
| Dec 31, 2013 | 2.42 Mn |
| Dec 31, 2013 | 2.42 Mn |
| Sep 30, 2013 | 2.79 Mn |
| Sep 30, 2013 | 2.79 Mn |
| Jun 30, 2013 | 2.69 Mn |
| Jun 30, 2013 | 2.69 Mn |
| Mar 31, 2013 | 2.49 Mn |
| Mar 31, 2013 | 2.49 Mn |
| Dec 31, 2012 | 2.77 Mn |
| Dec 31, 2012 | 2.77 Mn |
| Sep 30, 2012 | 1.62 Mn |
| Sep 30, 2012 | 1.62 Mn |
| Jun 30, 2012 | 1.48 Mn |
| Jun 30, 2012 | 1.48 Mn |
| Mar 31, 2012 | 1.53 Mn |
| Mar 31, 2012 | 1.53 Mn |
| Dec 31, 2011 | 893,000.00 |
| Dec 31, 2011 | 893,000.00 |
| Sep 30, 2011 | 651,000.00 |
| Sep 30, 2011 | 651,000.00 |
| Jun 30, 2011 | 37,000.00 |
| Jun 30, 2011 | 37,000.00 |
| Mar 31, 2011 | 54,000.00 |
| Mar 31, 2011 | 54,000.00 |